Unibest

Pharmaceutical intermediates

Peficitinib Hydrobromide Intermediates

2 pharmaceutical intermediates for Peficitinib Hydrobromide. Indication: Rheumatoid Arthritis.

提交项目All intermediates

About Peficitinib Hydrobromide

Originator
Astellas Pharma Inc.
Indication
Rheumatoid Arthritis

Available intermediates

2 intermediates currently listed for Peficitinib Hydrobromide. Request specifications, documentation or a quotation for any item below.

Peficitinib Hydrobromide intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
Methyl 4-chloro-1Hpyrrolo[2,3-b]pyridine-5-carboxylate951625-93-7//
Trans-4-Amino-1-hydroxyadamantane62058-03-1//

Other programs under P

PacritinibPalbociclibParecoxib sodiumParicalcitolPaxlovidPazopanib HydrochloridePemafibratePeramivir

Building toward Peficitinib Hydrobromide?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →